IMPACT OF SEROPOSITIVITY ON DRUG RETENTION OF BIOLOGICS AND JAK INHIBITORS -THE ANSWER COHORT STUDY

被引：0

作者：

Etani, Y. ^{[1
]}

Ebina, K. ^{[2
]}

Okita, Y. ^{[3
]}

Maeda, Y. ^{[3
]}

Tsujimoto, K. ^{[3
]}

Onishi, A. ^{[4
]}

Onizawa, H. ^{[4
]}

Okano, T. ^{[5
,9
]}

Nishimura, K. ^{[5
]}

Yoshikawa, A. ^{[6
]}

Shiba, H. ^{[6
]}

Amuro, H. ^{[7
]}

Son, Y. ^{[7
]}

Hashimoto, M. ^{[8
]}

Okano, T. ^{[5
,9
]}

Hara, R. ^{[10
]}

Yamamoto, W. ^{[11
]}

Kumanogoh, A. ^{[3
]}

Okada, S. ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka, Japan

[2] Osaka Univ, Grad Sch Med, Dept Musculoskeletal Regenerat Med, Osaka, Japan

[3] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Osaka, Japan

[4] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan

[5] Kobe Univ, Dept Rheumatol & Clin Immunol, Grad Sch Med, Kobe, Japan

[6] Osaka Med & Pharmaceut Univ, Dept Internal Med 4, Osaka, Japan

[7] Kansai Med Univ, Dept Internal Med 1, Osaka, Japan

[8] Osaka Metropolitan Univ, Grad Sch Med, Dept Clin Immunol, Osaka, Japan

[9] Osaka Metropolitan Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Japan

[10] Nara Med Univ, Dept Orthopaed Surg, Nara, Japan

[11] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Japan

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

bDMARD; Rheumatoid arthritis; Biomarkers;

D O I：

10.1136/annrheumdis-2023-eular.1114

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0407

引用

页码：1389 / 1389

页数：1

共 45 条

[21] Safety of JAK and IL-6 inhibitors in patients with rheumatoid arthritis: a multicenter cohort study [J].

Yoshida, Shuhei ;

Miyata, Masayuki ;

Suzuki, Eiji ;

Kanno, Takashi ;

Sumichika, Yuya ;

Saito, Kenji ;

Matsumoto, Haruki ;

Temmoku, Jumpei ;

Fujita, Yuya ;

Matsuoka, Naoki ;

Asano, Tomoyuki ;

Sato, Shuzo ;

Migita, Kiyoshi .

FRONTIERS IN IMMUNOLOGY, 2023, 14

[22] Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study [J].

Hayashi, Shinya ;

Tachibana, Shotaro ;

Maeda, Toshihisa ;

Yamashita, Mai ;

Shirasugi, Iku ;

Yamamoto, Yuzuru ;

Yamada, Hirotaka ;

Okano, Takaichi ;

Nishimura, Keisuke ;

Ueda, Yo ;

Jinnno, Sadao ;

Saegusa, Jun ;

Yamamoto, Wataru ;

Murata, Koichi ;

Fujii, Takayuki ;

Hata, Kenichiro ;

Yoshikawa, Ayaka ;

Ebina, Kosuke ;

Etani, Yuki ;

Yoshida, Naofumi ;

Amuro, Hideki ;

Hashimoto, Motomu ;

Hara, Ryota ;

Katayama, Masaki ;

Okano, Tadashi ;

Kuroda, Ryosuke .

RHEUMATOLOGY, 2023, 63 (11) :3033-3041

[23] Disease-modifying antirheumatic drug selection in Japanese patients with rheumatoid arthritis treated with biologics or JAK inhibitors without methotrexate: A retrospective hospital-based administrative claims database study [J].

Miyakawa, Naohisa ;

Tsuritani, Katsuki ;

Teixeira, Bruno Casaes ;

Fujio, Keishi .

MODERN RHEUMATOLOGY, 2024, 34 (05) :900-909

[24] Effectiveness and Drug Survival of TNF Inhibitors in the Treatment of Ankylosing Spondylitis: A Prospective Cohort Study [J].

Heinonen, Arto V. ;

Aaltonen, Kalle J. ;

Joensuu, Jaana T. ;

Lahteenmaki, Jukka P. ;

Pertovaara, Marja I. ;

Romu, Matti K. ;

Hirvonen, Hanna E. ;

Simila, Aki K. ;

Blom, Marja L. ;

Nordstrom, Dan C. .

JOURNAL OF RHEUMATOLOGY, 2015, 42 (12) :2339-2346

[25] Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study [J].

A. Shin ;

E.H. Park ;

Y.-H. Dong ;

Y.-J. Ha ;

Y.J. Lee ;

E.B. Lee ;

Y.W. Song ;

E.H. Kang .

Osteoporosis International, 2020, 31 :2131-2139

[26] A REAL-LIFE COMPARATIVE STUDY OF JAK INHIBITORS AND TNF INHIBITORS IN RHEUMATOID ARTHRITIS WITH DRUG DISPENSING DATA FROM RETAIL PHARMACIES IN FRANCE [J].

Sambourg, J. ;

Gouverneur, A. ;

Bardoulat, I. ;

Schaeverbeke, T. ;

Truchetet, M. E. ;

Maravic, M. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :400-400

[27] Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study [J].

Nakayama, Yoichi ;

Onishi, Akira ;

Yamamoto, Wataru ;

Yoshikawa, Ayaka ;

Shiba, Hideyuki ;

Yoshida, Naofumi ;

Son, Yonsu ;

Shirasugi, Iku ;

Maeda, Toshihisa ;

Katsushima, Masao ;

Hashimoto, Motomu ;

Etani, Yuki ;

Itami, Tetsu ;

Nozaki, Yuji ;

Onizawa, Hideo ;

Fujii, Takayuki ;

Murakami, Kosaku ;

Murata, Koichi ;

Tanaka, Masao ;

Matsuda, Shuichi ;

Morinobu, Akio .

CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)

[28] Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study [J].

Shin, A. ;

Park, E. H. ;

Dong, Y-H ;

Ha, Y-J ;

Lee, Y. J. ;

Lee, E. B. ;

Song, Y. W. ;

Kang, E. H. .

OSTEOPOROSIS INTERNATIONAL, 2020, 31 (11) :2131-2139

[29] Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles [J].

Silvagni, Ettore ;

Bortoluzzi, Alessandra ;

Occhino, Giuseppe ;

Bellelli, Giuseppe ;

Garaffoni, Carlo ;

Delvino, Paolo ;

Leoni, Olivia ;

Valsecchi, Maria Grazia ;

Scire, Carlo Alberto ;

Rebora, Paola .

FRONTIERS IN PHARMACOLOGY, 2025, 16

[30] The Impact of Seropositivity on Systemic Bone Loss in Rheumatoid Arthritis-A 3-Year Interim Analysis of a Longitudinal Observational Cohort Study [J].

Yu, Shan-Fu ;

Chen, Jia-Feng ;

Chen, Ying-Chou ;

Wang, Yu-Wei ;

Hsu, Chung-Yuan ;

Lai, Han-Ming ;

He, Hsiao-Ru ;

Ko, Chi-Hua ;

Chiu, Wen-Chan ;

Cheng, Tien-Tsai .

FRONTIERS IN MEDICINE, 2022, 9

← 1 2 3 4 5 →